Oral bioavailability of omeprazole before and after chronic therapy in patients with duodenal ulcer.-Reference-Cited by-同舟云学术

Oral bioavailability of omeprazole before and after chronic therapy in patients with duodenal ulcer.

Published:1991-02 Issue:2 Volume:31 Page:166-170
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:British Journal of Clinical Pharmacology

Author:

Ching MS,Mihaly GW,Angus PW,Morgan DJ,Devenish-Meares S.,Yeomans ND,Smallwood RA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1991.tb05506.x/fullpdf

Reference20 articles.

1. Omeprazole pharmacokinetics of a single and repeated once daily administration of 10, 20 and 40 mg as enteric coated granules;Andersson;Eur. J. clin. Pharmac.,1989

2. Interactions between nifedipine and omeprazole;Danhof;Eur. J. clin. Pharmac.,1989

3. Inhibition of acid secretion in isolated glands by substituted benzimidazoles;Fellenius;Am. J. Physiol.,1982

4. Pharmacokinetics

5. Hepatic vascular bed;Greenway;Physiol. Rev.,1971

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling and Simulation of Pretomanid Pharmacokinetics in Pulmonary Tuberculosis Patients;Antimicrobial Agents and Chemotherapy;2018-07

2. Pharmacokinetics and antitumor activity of patupilone combined with midazolam or omeprazole in patients with advanced cancer;Cancer Chemotherapy and Pharmacology;2011-04-17

3. Proton Pump Inhibitor Therapy and Osteoporosis;Current Drug Safety;2008-09-01

4. Synthesis of Omeprazole Analogues and Evaluation of These as Potential Inhibitors of the Multidrug Efflux Pump NorA of Staphylococcus aureus;Antimicrobial Agents and Chemotherapy;2007-03

5. Possible Interethnic Differences in Omeprazole Pharmacokinetics;Clinical Pharmacokinetics;2006